Cue Biopharma, Inc. (CUE)
27.82
+5.49
(+24.59%)
USD |
NASDAQ |
Oct 09, 16:00
27.87
+0.05
(+0.18%)
After-Hours: 19:35
Cue Biopharma Price : 27.82 for Oct. 9, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 08, 2026 | 22.38 | 22.74 | 21.60 | 22.33 | 109897.0 |
| Oct 07, 2026 | 22.92 | 23.10 | 22.27 | 22.51 | 133170.0 |
| Oct 06, 2026 | 24.22 | 24.89 | 22.92 | 23.14 | 174849.0 |
| Oct 05, 2026 | 25.60 | 25.94 | 22.21 | 24.36 | 272651.0 |
| Oct 02, 2026 | 25.60 | 25.92 | 24.67 | 25.57 | 157037.0 |
| Oct 01, 2026 | 26.00 | 26.02 | 24.60 | 25.25 | 183432.0 |
| Sep 30, 2026 | 25.89 | 27.43 | 24.88 | 25.87 | 228119.0 |
| Sep 29, 2026 | 28.15 | 28.15 | 24.13 | 25.51 | 283904.0 |
| Sep 28, 2026 | 30.86 | 32.07 | 27.01 | 27.45 | 237825.0 |
| Sep 25, 2026 | 33.12 | 33.40 | 30.75 | 31.41 | 232444.0 |
| Sep 24, 2026 | 31.15 | 33.64 | 30.44 | 32.85 | 330396.0 |
| Sep 23, 2026 | 29.91 | 35.23 | 29.86 | 31.71 | 696484.0 |
| Sep 22, 2026 | 28.61 | 32.39 | 25.49 | 30.90 | 1.206M |
| Sep 21, 2026 | 38.50 | 41.50 | 23.80 | 28.27 | 3.541M |
| Sep 18, 2026 | 39.35 | 41.00 | 35.54 | 37.05 | 381952.0 |
| Sep 17, 2026 | 34.75 | 38.07 | 34.20 | 37.84 | 195083.0 |
| Sep 16, 2026 | 31.27 | 36.47 | 30.32 | 34.17 | 277390.0 |
| Sep 15, 2026 | 30.65 | 32.00 | 29.26 | 31.64 | 127172.0 |
| Sep 14, 2026 | 28.24 | 31.10 | 28.24 | 30.55 | 136595.0 |
| Sep 11, 2026 | 28.38 | 28.89 | 27.50 | 28.74 | 122768.0 |
| Sep 10, 2026 | 30.20 | 30.90 | 27.50 | 28.00 | 143189.0 |
| Sep 09, 2026 | 30.00 | 32.13 | 30.00 | 30.50 | 174151.0 |
| Sep 08, 2026 | 27.39 | 30.24 | 25.62 | 30.00 | 260042.0 |
| Sep 04, 2026 | 27.55 | 27.95 | 27.02 | 27.44 | 50416.00 |
| Sep 03, 2026 | 26.60 | 28.09 | 26.60 | 27.67 | 65684.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Xilio Therapeutics, Inc. | 9.08 |
| ACADIA Pharmaceuticals, Inc. | 19.78 |
| Alnylam Pharmaceuticals, Inc. | 232.52 |
| Savara, Inc. | 4.925 |
| Vericel Corp. | 40.09 |
Price Related Metrics
| PS Ratio | 3.361 |
| PEG Ratio | -0.0035 |
| Price to Book Value | 62.98 |
| Earnings Yield | -97.06% |
| Market Cap | 145.48M |
| PEGY Ratio | -0.0035 |